StockWatch
·
Biotechnology: Pharmaceutical Preparations
Corporate ActionJun 18, 2026, 04:07 PM

Genprex Stockholders Approve Reverse Split, Equity Plan Increase

AI Summary

Genprex, Inc. stockholders approved an amendment to the Certificate of Incorporation to effect a reverse stock split, allowing the Board to implement a ratio between one-for-five (1:5) and one-for-fifty (1:50) by December 31, 2027. Additionally, the company's amended and restated 2018 Equity Incentive Plan was approved, increasing the number of shares authorized for issuance by 1,850,000. Stockholders also elected two Class III directors, ratified the appointment of the independent registered public accounting firm, and approved the advisory vote on executive compensation.

Key Highlights

  • Stockholders approved an amendment for a reverse stock split (1:5 to 1:50 ratio) by December 31, 2027.
  • The Amended Equity Plan was approved, increasing authorized shares by an additional 1,850,000.
  • Jose Antonio Moreno Toscano was elected as a Class III director with 868,543 votes for.
  • Ryan M. Confer was elected as a Class III director with 877,370 votes for.
  • The appointment of WithumSmith+Brown, PC as independent auditor was ratified with 4,284,497 votes for.
  • The advisory vote on Named Executive Officers' compensation was approved with 681,841 votes for.